A Bayesian approach to randomized controlled trials in children utilizing information from adults: The case of Guillain-Barré syndrome

Clinical Trials

Volumn 2, Issue 4, 2005, Pages 305-310

  Goodman, Steven N ^a   Sladky, John T ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; PLACEBO;

ADULT; BAYES THEOREM; CASE STUDY; CHILD; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; EVIDENCE BASED MEDICINE; GUILLAIN BARRE SYNDROME; HUMAN; IMMUNOLOGICAL TOLERANCE; INTERMETHOD COMPARISON; MOBILIZATION; PARALYSIS; PLASMAPHERESIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; TREATMENT PLANNING;

ADULT; BAYES THEOREM; CHILD; EVIDENCE-BASED MEDICINE; GUILLAIN-BARRE SYNDROME; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; PLASMAPHERESIS; RANDOMIZED CONTROLLED TRIALS; TREATMENT OUTCOME; WALKING;

EID: 24944463173     PISSN: 17407745     EISSN: 17407753     Source Type: Journal    
DOI: 10.1191/1740774505cn102oa     Document Type: Conference Paper

References (23)

1. Rantala H, Uhari M, Niemela M. Occurrence, clinical manifestations, and prognosis of Guillain-Barre syndrome. Arch Dis Child 1991; 66: 706-8; discussion 708-9.
2. Albers JW, Kelly JJJ. Acquired inflammatory demyelinating polyneuropathies: clinical and electrodiagnostic features. Muscle Nerve 1989; 12: 435-51.
3. Bradshaw DY, Jones HRJ. Guillain-Barre syndrome in children: clinical course, electrodiagnosis, and prognosis. Muscle Nerve 1992; 15: 500-6.
4. Kleyweg RP, van der Meche FG. Treatment related fluctuations in Guillain-Barre syndrome after high-dose immunoglobulins or plasma-exchange. J Neurol Neurosurg Psychiatry 1991; 54: 957-60.
5. Sladky JT. Neuropathy in childhood. Semin Neurol 1987; 7: 67-75.
6. Briscoe DM, McMenamin JB, O'Donohoe NV. Prognosis in Guillain-Barre syndrome. Arch Dis Child 1987; 62: 733-5.
7. Cole GF, Matthew DJ. Prognosis in severe Guillain-Barre syndrome. Arch Dis Child 1987; 62: 288-91.
8. McKhann GM, Griffin JW, Cornblath DR, Mellits ED, Fisher RS, Quaskey SA. Plasmapheresis and Guillain-Barre syndrome: analysis of prognostic factors and the effect of plasmapheresis. Ann Neurol 1988; 23: 347-53.
9. Korinthenberg R, Monting JS. Natural history and treatment effects in Guillain-Barre syndrome: a multicentre study. Arch Dis Child 1996; 74: 281-7.
10. The Guillain-Barre syndrome Study Group. Plasmapheresis and acute Guillain-Barre syndrome. Neurology 1985; 35: 1096-104.
11. French Cooperative Group on Plasma Exchange in Guillain-Barre syndrome. Efficiency of plasma exchange in Guillain-Barre syndrome: role of replacement fluids. Ann Neurol 1987; 22: 753-61.
12. Khatri BO, Flamini JR, Baruah JK, Dobyns WB, Konkol RJ. Plasmapheresis with acute inflammatory polyneuropathy. Pediatr Neurol 1990; 6: 17-19.
13. Lamont PJ, Johnston HM, Berdoukas VA. Plasmapheresis in children with Guillain-Barre syndrome. Neurology 1991; 41: 1928-31.
14. Epstein MA, Sladky JT. The role of plasmapheresis in childhood Guillain-Barre syndrome. Ann Neurol 1990; 28: 65-9.
15. al-Qudah AA. Immunoglobulins in the treatment of Guillain-Barre syndrome in early childhood. J Child Neurol 1994; 9: 178-80.
16. Gurses N, Uysal S, Cetinkaya F, Islek I, Kalayci AG. Intravenous immunoglobulin treatment in children with Guillain-Barre syndrome. Scand J Infect Dis 1995; 27: 241-3.
17. van der Meche FG, Schmitz PI. A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barre syndrome. Dutch Guillain-Barre Study Group. N Engl J Med 1992; 326: 1123-9.
18. Plasma Exchange/Sandoglobulin Guillain-Barre Syndrome Trial Group. Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barre syndrome. Lancet 1997; 349: 225-30.
19. Paradiso G, Tripoli J, Galicchio S, Fejerman N. Epidemiological, clinical, and electrodiagnostic findings in childhood Guillain-Barre syndrome: a reappraisal. Ann Neurol 1999; 46: 701-7.
20. Graf WD, Katz JS, Eder DN, Smith AJ, Chun MR. Outcome in severe pediatric Guillain-Barre syndrome after immunotherapy or supportive care. Neurology 1999; 52: 1494-7.
21. Jansen PW, Perkin RM, Ashwal S. Guillain-Barre syndrome in childhood: natural course and efficacy of plasmapheresis. Pediatr Neurol 1993; 9: 16-20.
22. Zafeiriou DI, Kontopoulos EE, Katzos GS, Gombakis XP, Kanakoudi FG. Single dose immunoglobulin therapy for childhood Guillain-Barre syndrome. Brain Dev 1997; 19: 323-5.
23. Kanra G, Ozon A, Vajsar J, Castagna L, Secmeer G, Topaloglu H. Intravenous immunoglobulin treatment in children with Guillain-Barre syndrome. Eur J Paediatr Neurol 1997; 1: 7-12.